Lipoprotein (a) and Anticardiolipin Antibodies as Risk Factors for Vascular Disease in Rheumatoid Arthritis

• References

• 1 Rankinen T, Välsänen S, Mercuri M, Raurama R. Apolipoprotein (a), fibrinopeptide A and carotid atherosclerosis in middle-aged men. Thromb Haemost 1994; 72: 563-566
• 2 Yamazaki M, Asakura H, Jokaji H, Saito M, Uotani C, Kumabashiri I, Morishita E, Aoshima K, Ikeda T, Matsuda T. Plasma levels of lipoprotein (a) are elevated in patients with antiphospholipid antibody syndrome. Thromb Haemost 1994; 71: 424-427
• 3 Seriolo B, Accardo S, Cutolo M. von Willebrand factor and vascular injury in rheumatoid arthritis. Ann Rheum Dis 1994; 53: 550
• 4 Hughes GRV. The antiphospholipid syndrome: ten years on. Lancet 1993; 342: 341-344
• 5 Seriolo B, Cutolo M, Fasciolo D, Accardo S. Anticardiolipin antibodies in rheumatoid arthritis. Ann Rheum Diss 1992; 51: 1100
• 6 Fort JG, Cowchock FS, Abruzzo JL, Smith JB. Anticardiolipin antibodies in patients with rheumatic diseases. Arthritis Rheum 1987; 30: 752-760
• 7 Loizou S, McCrea JD, Rudge AC, Reynolds R, Boyle CC, Harris EN. Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantification of results. Clin Exp Immunol 1985; 62: 738-745
• 8 Seriolo B, Cutolo M, Fasciolo D, Accardo S. Lipoprotein(a) and anticardiolipin antibody concentration in rheumatoid arthritis. Arthritis Rheum 1994; 37: 248
• 9 Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986; 74: 2540-2544
• 10 Edelberg JM, Pizzo SV. Lipoprotein(a) inhibits plasminogen activation in a template-dependent manner. Blood Coagulat Fibrinol 1991; 2: 759-764
• 11 Harris NN, Asherson RA, Gharavi AE, Morgan SH, Derue GD, Hughes GRV. Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody. Br J Haematol 1985; 59: 227-230